CliffBio
small molecule

AMCINONIDE

AMCINONIDE

Loss of exclusivity—loss of exclusivity
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameAMCINONIDE
Active ingredientAMCINONIDE
Strength0.1%
Dosage formOINTMENT
RouteTOPICAL
ModalitySmall molecule
FDA approvalNovember 2002
Marketing statusRX

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

AMCINONIDE patent cliff — loss of exclusivity — | CliffBio